RxDoctor Payments Data

Emily Perkins, MD

Family Medicine · Greenwood, INNPI 1396132031

Payments from drug & device makers

$415in general payments, 2019–2025

Across 30 payments — averaging $13.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$73
  • Amgen$49
  • Takeda Pharmaceuticals U.S.A., Inc.$47
  • Boehringer Ingelheim$38
  • GSK$37
  • Amarin Pharma, Inc.$30
  • plus $139 from 9 others

What the payments were for

  • Food & beverage$415100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$415 in reported general payments places this provider in the 45th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$72,144
Medicare patients
167
Services billed
1,095

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide52$81,627
JardianceEmpagliflozin26$41,989
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$20,459
MounjaroTirzepatide14$18,838
EliquisApixaban11$18,441
LinzessLinaclotide12$15,731
Breo ElliptaFluticasone/Vilanterol15$10,323
SynthroidLevothyroxine Sodium39$2,853
Gabapentin160$2,701
Atorvastatin Calcium415$2,588
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen141$2,558
Omeprazole166$2,094
Levothyroxine Sodium231$1,925
Pantoprazole Sodium105$1,693
Ezetimibe37$1,600

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$16$81,62752 claims
Boehringer IngelheimJardiance$38$41,98926 claims
GSKTrelegy Ellipta, Breo Ellipta$37$30,78333 claims
Lilly USA, LLCMounjaro$73$18,83814 claims
PfizerEliquis$11$18,44111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Greenwood

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →